Cargando…

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination

Detalles Bibliográficos
Autores principales:	Muir, Kate-Lynn, Kallam, Avyakta, Koepsell, Scott A., Gundabolu, Krishna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063883/ https://www.ncbi.nlm.nih.gov/pubmed/33852795 http://dx.doi.org/10.1056/NEJMc2105869

Ejemplares similares

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination — Response from the Manufacturer
por: Sadoff, Jerald, et al.
Publicado: (2021)

Persistence of Ad26.COV2.S‐associated vaccine‐induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies
por: Kanack, Adam J., et al.
Publicado: (2022)

Ad26.COV2-S: Thrombotic thrombocytopenia: case report
Publicado: (2021)

Ad26.cov2-s: Thrombotic thrombocytopenia: case report
Publicado: (2022)

Ad26.COV2-S: Thrombotic thrombocytopenia: case report
Publicado: (2021)

Ad26.COV2-S: Immune thrombotic thrombocytopenia: case report
Publicado: (2022)

Ad26.cov2-s: Immune thrombotic thrombocytopenia: case report
Publicado: (2022)

Ad26.cov2-s: Immune-thrombotic thrombocytopenia: case report
Publicado: (2022)

Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S Vaccination
por: Yocum, Andrew, et al.
Publicado: (2021)

Ad26.COV2-S/AZD-1222: Thrombotic thrombocytopenia: 5 case reports
Publicado: (2022)

Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination
por: Clark, Richard Todd, et al.
Publicado: (2021)

PF4 Immunoassays in Vaccine-Induced Thrombotic Thrombocytopenia
por: Vayne, Caroline, et al.
Publicado: (2021)

Ad26.COV2-S: Thrombotic thrombocytopenia and cerebral venous sinus thrombosis: case report
Publicado: (2021)

Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Patriquin, Christopher J., et al.
Publicado: (2021)

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
por: Greinacher, Andreas, et al.
Publicado: (2021)

Lymphohistocytic myocarditis after Ad26.COV2.S viral vector COVID-19 vaccination
por: Ujueta, Francisco, et al.
Publicado: (2021)

Kidney Transplantation from a Deceased Donor with COVID-19 Ad26.COV2-S Vaccine-Induced Thrombotic Thrombocytopenia
por: Neretljak, Ivan, et al.
Publicado: (2023)

Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study
por: Takuva, Simbarashe, et al.
Publicado: (2021)

Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination
por: Barouch, Dan H., et al.
Publicado: (2021)

Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26.COV2.S vaccination
por: Kulkarni, Prathit A., et al.
Publicado: (2021)

Comment on “Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US
por: Rodriguez, Elsa V. C., et al.
Publicado: (2021)

Ad26.cov2-s/AZD-1222: Cerebral venous sinus thrombosis and thrombotic thrombocytopenia: 3 case reports
Publicado: (2022)

Ad26.COV2-S: Thrombocythemia-thrombotic: case report
Publicado: (2022)

COVID‐19 mRNA‐1273 vaccine induces production of vaccine‐induced immune thrombotic thrombocytopenia antibodies
por: Padmanabhan, Anand, et al.
Publicado: (2022)

Upper Limb Phlegmasia Cerulea Dolens Secondary to Heparin-induced Thrombocytopenia Leading to Gangrene
por: Kommalapati, Anuhya, et al.
Publicado: (2018)

Ad26.COV2-S: Transient thrombocytopenia: case report
Publicado: (2022)

Antibody Response to the Coronavirus Disease 2019 Ad26.COV2.S Vaccine Among Maintenance Dialysis Patients
por: Ficociello, Linda H., et al.
Publicado: (2022)

Thrombus Distribution in Vaccine-induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
por: Rogers, Priya, et al.
Publicado: (2022)

Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa
por: Gray, Glenda, et al.
Publicado: (2022)

Thrombocytopenia after Ad.26.COV2.S COVID-19 vaccine: Reports to the vaccine adverse event reporting system
por: Woo, Emily Jane, et al.
Publicado: (2022)

Challenges in nodal peripheral T-cell lymphomas: from biological advances to clinical applicability
por: Zain, Jasmine, et al.
Publicado: (2023)

Ad26.cov2-s: Thrombotic thrombocytopenic purpura: case report
Publicado: (2022)

Letter to editor – observation on the article titled “Vaccine-Induced Thrombotic Thrombocytopenia (VITT): first report from India”
por: Kotwal, Jyoti, et al.
Publicado: (2023)

First tonic-clonic seizure five hours after Ad26.COV2.S vaccination without acute brain lesion but long-term chorea
por: de Almeida, Antonio-Carlos M., et al.
Publicado: (2023)

Case Report: Hypergranular Platelets in Vaccine-Induced Thrombotic Thrombocytopenia After ChAdOx1 nCov-19 Vaccination
por: Comer, Shane P., et al.
Publicado: (2022)

Ad26.cov2-s: Thrombosis with thrombocytopenia syndrome: case report
Publicado: (2022)

Thrombotic Thrombocytopenic Purpura After Ad6.COV2.S Vaccination
por: Ramanan, Sruthi, et al.
Publicado: (2022)

Severe Thrombocytopenia Two Weeks Following Immunization with the Janssen Ad26.CoV2.S Vaccine
por: Antonios, Bana, et al.
Publicado: (2022)

Ad26.cov2-s: Thrombosis with thrombocytopenia syndrome: 3 case reports
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eofcmdgptciv064o637d8ea8ug